Program:
Start Year:
2021
Why did you choose Duke for your residency training?
When choosing a residency program, I was looking for a program that serves a diverse patient population, provides exposure to subspecialties within Ob/Gyn, encourages involvement in impactful clinical research and fosters a sense of community service and patient advocacy among its residents. I was thrilled to discover that Duke checked off all these boxes! Perhaps more importantly, I was impressed with the supportive community of fellow residents, mentors and faculty who truly care for not only my professional development, but for my personal wellbeing!
What excites you about the residency program at Duke OB/GYN?
I am so excited to train alongside such driven and diverse residents who prioritize women's health needs for all members of our community. I am also excited to learn from Duke's amazing faculty members, whose dedication to the advancement of the field of Ob/Gyn is incredibly inspiring. And, most importantly, I am excited and privileged to have the opportunity to care for the women of Durham!
What are your career goals?
I chose the field of Ob/Gyn because I am passionate about providing women's health care to members of traditionally underserved and
marginalized communities. To this end, I would like to specifically focus my training on patient and community education/advocacy, medical
education, global and public health and high-risk obstetrics.
Describe your research interests/goals:
My research interests include sickle cell disease in pregnancy, maternal mortality, and improvement of access and clinical outcomes in low-resource settings.
What are your hobbies?
Anything outdoors! I love trail running, backpacking and camping.
Education & Training
Medical school & graduation year:
University of Portland, 2014
Medical school & graduation year:
Virginia Tech Carilion School of Medicine, 2021
Publications & Presentations
Tanenbaum M.T., Shvygina A., Sridhar V., Vaughn J.E., Joseph M.. (2019, November 13). Identification of the Pitfalls in the Attempted
Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
Alvarez, A., Bevers, K., Bu, D., Cain, A., Macintosh-Clarke D., Murphy, L., Rivera, D., Shvygina, A., Soin, A.. (2020, October 02). Laying the First Steps Towards a Transition to a Financial and Citizenship Need Blind Model for Organ Procurement and Transplantation
Tanenbaum, M.T., Shvygina, A., Sridhar, V., Vaughn, J.E., Joseph, M.. (2020, June 29). The Use of Extracorporeal Membrane Oxygenation During Acute Chest
Crisis in an Adult Sickle Cell Disease Patient: Identification of Pearls and Pitfalls
Uchida N., Washington K.N., Mozer B., Platner C., Ballantine J., Skala L.P., Raines L., Shvygin A., Hsieh M.M., Mitchell L.G., Tisdale J.F.. (2017, Apr). RNA trans-splicing targeting endogenous globin pre-messenger RNA in human erythroid cells.. Human Gene Therapy Methods, 28(2), 91-99
Uchida N., Weitzel R.P., Shvygin A., Skala L.P., Raines L., Bonifacino A.C., Krouse A.E., Metzger M.E., Donahue R.E., Tisdale J.F.. (2016, Jul). Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus stem cell gene therapy model. Molecular Therapy-Methods and Clinical Development, 3(1), 16059
Presentations
Shvygina A., Roghanizad A.R., Diller, T., Moses, E. S., Permashwar, V., Borowicz, V. M., Vaughn, J. E.. (2021, March 01). The CHFT+ Sensor:
A Novel Method of Measuring Perfusion Abnormalities in Sickle Cell Disease. VTCSOM Medical Student Research Symposium/Roanoke, VA,
USA
Johnson, N.M., Shvygina, A., Luyimbazi, D., Grider, D.J.. (2020, November 01). Erythema ab Igne with Reactive Angiomatosis: A Histologic Mimic of
Angiosarcoma. [Poster presented]. American Society of Dermatopathology 2020 Virtual Annual Meeting/Chicago, IL, USA
Shvygina, A., Roghanizad, A., Murray, C., Moses, E., Borowicz, V. M., Vaughn, J.E., Diller, T.. (2020, October 01). The CHFT+ Sensor: A Novel Method to Measure Perfusion Abnormalities in Sickle Cell Disease. Biomedical Engineering Society Virtual Annual Meeting/San Diego, CA, USA
Sridhar V., Shvygina A., Atkinson M.M.. (2020, May 01). Hemoglobin Hammersmith Presenting as Asymptomatic Anemia in 1-year Old Female. American Society of Pediatric Hematology and Oncology Conference/Fort Worth, TX, USA
Uchida N., Haro-Mora J., Fujita A., Raines L., Shvygin A., Skala L., Hsieh M., Tisdale J.. (2017, May 01). A Serum-Free Method for Efficient Genetic Modification and High-Level Hemoglobin Production in Human CD34+Cell-Derived Erythroid Cells. [Poster presented]. Annual Meeting of the American Society of Gene and Cell Therapy/Washington, DC, USA
Uchida N., Shvygin A., Raines L., Mora J.J.H., Demirci S., Hsieh M.M., Tisdale J.F.. (2017, December 01). Selective Proliferation of Gene- Modified Human Erythroid Cells with Truncated Erythropoietin Receptors. [Poster presented]. American Society of Hematology Annual Meeting/Atlanta, GA, USA
Uchida N., Shvygin A., Skala L., Raines L., Ballantine J., Tisdale J.. (2016, May 01). Development of a Cas9 Protein Delivery System with Lentiviral Vectors for RNA-Guided Genome Editing. Annual Meeting of the American Society of Gene and Cell Therapy/Washington, DC, USA